Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Metropolis Healthcare Limited provides diagnostic services in India and internationally. The company offers clinical laboratory testing, and profiles services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, and confirmation and/or monitoring of the disease. In addition, the company offers corporate wellness, laboratory in, and clinical research services. Metropolis Healthcare Limited was founded in 1981 and is headquartered in Mumbai, India.

Revenue projections:

Revenue projections for METROPOLIS
Revenue projections for METROPOLIS

Investors may react cautiously to news that METROPOLIS's revenues are forecasted to be lower than last year's. Such declines are likely to have a negative effect on the company's bottom line, which can lead to concerns about profitability and hinder investor confidence in the company's future performance.

Financial Ratios:

currentRatio 0.00000
forwardPE 41.03531
debtToEquity 15.95600
earningsGrowth 0.15300
revenueGrowth 0.10900
grossMargins 0.77861
operatingMargins 0.13729
trailingEps 29.62000
forwardEps 0.00000

METROPOLIS's low Debt-to-Equity ratio reflects the company's conservative use of debt. This shows that it isn't over-leveraged, reducing financial risk and indicating a stable financial structure, which is a positive signal for investors concerned about excessive debt burdens.
METROPOLIS's positive earnings and revenue growth signal that the company is expected to expand its business. This healthy financial trend reflects an optimistic outlook, suggesting continued growth in both sales and profits for METROPOLIS.

Price projections:

Price projections for METROPOLIS
Price projections for METROPOLIS

METROPOLIS's price projections have been steadily revised down, pointing to declining confidence in the company's outlook. This suggests that analysts are becoming more conservative in their expectations for METROPOLIS's future performance.

Insider Transactions:

Insider Transactions for METROPOLIS
Insider Transactions for METROPOLIS


Metropolis Healthcare Limited saw 2 transactions in which shares were sold with market price at 2095.9249267578125.No sell transactions occurred in the period under review.The recent buying activity at current METROPOLIS price levels exceeds selling, suggesting a potential positive outlook. Investors may see this trend as an indicator that the stock is likely to perform well, reflecting growing confidence.

Recommendation changes over time:

Recommendations trend for METROPOLIS
Recommendations trend for METROPOLIS


Analysts' buy bias for METROPOLIS signals that the stock is considered a favorable investment. This outlook might prompt investors to allocate funds to METROPOLIS, seeing it as a solid and profitable choice to park their money and potentially benefit from the company's long-term growth.